Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative timing of recombinant human erythropoietin plus iron for anemia in total knee arthroplasty
ChiCTR1900026065Phase 4Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Sep 2019
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of erythropoietin and Iron in iron deficiency anemia (IDA) (3 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: transfusion rate, hemoglobin and 1 more. Started Sep 2019; status: recruiting.
02
Drugs
erythropoietinIron
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on ChiCTR1900026065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900026065.